Tango Therapeutics, Inc. — Investor Relations & Filings
Filings indexed
355
across all filing types
Latest filing
2021-02-16
Major Shareholding Noti…
Country
US
United States of America
Listing
US
TNGX
Tango Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to discovering and developing a new generation of precision oncology medicines. The company's approach is centered on the principle of synthetic lethality, a genetic strategy to target cancer vulnerabilities. By utilizing its proprietary drug discovery platform, which integrates CRISPR technology, Tango identifies novel drug targets and develops therapies for genetically defined patient populations with unmet medical needs. The company's pipeline is designed to deliver transformative medicines that take direct aim at specific tumors, with the goal of expanding the reach of genetically targeted cancer therapies.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| SC 13G | 2021-02-16 | English | |
| SCHEDULE 13G | 2021-02-16 | English | |
| Director's Dealing 2020 | 2020-11-25 | English | |
| QUARTERLY REPORT | 2020-11-13 | English | |
| CURRENT REPORT | 2020-10-07 | English | |
| Director's Dealing 2020 | 2020-10-07 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2021
2 filings
| |||||
| 13278359 | SC 13G | 2021-02-16 | English | ||
| 13278362 | SCHEDULE 13G | 2021-02-16 | English | ||
|
2020
13 filings
| |||||
| 13278360 | Director's Dealing 2020 | 2020-11-25 | English | ||
| 13278361 | QUARTERLY REPORT | 2020-11-13 | English | ||
| 13278364 | CURRENT REPORT | 2020-10-07 | English | ||
| 13278363 | Director's Dealing 2020 | 2020-10-07 | English | ||
| 13278365 | CURRENT REPORT | 2020-09-14 | English | ||
| 13278366 | Director's Dealing 2020 | 2020-09-11 | English | ||
| 13278368 | CURRENT REPORT | 2020-09-09 | English | ||
| 13278370 | PROSPECTUS SUPPLEMENT | 2020-09-04 | English | ||
| 13278371 | Director's Dealing 2020 | 2020-09-03 | English | ||
| 13278372 | Director's Dealing 2020 | 2020-09-03 | English | ||
| 13278373 | Director's Dealing 2020 | 2020-09-03 | English | ||
| 13278374 | Regulatory Filings 2020 | 2020-09-03 | English | ||
| 13278375 | Director's Dealing 2020 | 2020-09-03 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
Tango Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32459/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32459 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32459 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32459 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32459}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Tango Therapeutics, Inc. (id: 32459)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.